Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 18, 2026
Real-world outcomes of cladribine in people ≥55 years of age with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 24, 2025
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Journal: Advances in therapy
Published: August 23, 2024
Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: May 22, 2024
Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT).
Journal: Medicina (Kaunas, Lithuania)
Published: March 22, 2024
Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 15, 2023
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 13, 2021
Vessel Wall Enhancement in Unilateral Primary Angiitis of the Central Nervous System.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: June 02, 2021
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).
Journal: CNS drugs
Published: April 28, 2021
Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.
Journal: BMJ neurology open
Published: October 16, 2020
COVID-19 in MS: Initial observations from the Pacific Northwest.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 14, 2020
Last Updated: 09/26/2026